Brief: Ascendas Genomics Receives Nmpa Approval For Use Of Standard Biotools Microfluidics Technology To Advance The Development Of Molecular Diagnostics In China
13/10/2022 13:40
Oct 13 (Reuters) - Standard BioTools Inc LAB.O :
* ASCENDAS GENOMICS RECEIVES NMPA APPROVAL FOR USE OF
STANDARD
BIOTOOLS MICROFLUIDICS TECHNOLOGY TO ADVANCE THE DEVELOPMENT OF
MOLECULAR DIAGNOSTICS IN CHINA
Source text for Eikon: ID:nGNXPw3GX
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07